The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 17, 2020

Filed:

Jul. 15, 2019
Applicant:

The Trustees of the University of Pennsylvania, Philadelphia, PA (US);

Inventors:

Mark Sellmyer, Philadelphia, PA (US);

Robert H. Mach, Wallingford, PA (US);

David A. Mankoff, Philadelphia, PA (US);

Iljung Lee, Secane, PA (US);

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 51/04 (2006.01); A61K 49/00 (2006.01); A61K 31/395 (2006.01); A61K 31/495 (2006.01); C07D 239/49 (2006.01); C07D 403/12 (2006.01); A61K 47/54 (2017.01); A61K 31/505 (2006.01);
U.S. Cl.
CPC ...
A61K 51/0459 (2013.01); A61K 31/395 (2013.01); A61K 31/495 (2013.01); A61K 31/505 (2013.01); A61K 47/547 (2017.08); A61K 49/0021 (2013.01); A61K 49/0052 (2013.01); A61K 51/0453 (2013.01); A61K 51/0497 (2013.01); C07D 239/49 (2013.01); C07D 403/12 (2013.01); C07B 2200/05 (2013.01); Y02A 50/473 (2018.01); Y02A 50/481 (2018.01);
Abstract

The present invention provides radiolabeled trimethoprim which are useful in imaging tests such as PET scans. The compounds show robust bacterial uptake in vitro and identify infections from inflammation or tumor when administered to a subject. The compounds show rapid and sensitive detection of Ec DHFR containing tumors from control tumors and background tissue. In one aspect, a compound having the structure of formula (I) is provided or a pharmaceutically acceptable salt or prodrug thereof, wherein R is defined herein. Also provided are compositions containing these compounds, positron emission tomography reporter probe comprising these compounds, and methods of imaging a bacterial infection, tracking or monitoring bacteria, distinguishing a bacterial infection from inflammation or tumor, monitoring genetically fused protein expression, and monitoring genetically engineered cells in clinical scenarios such as immunotherapy for cancer treatment.


Find Patent Forward Citations

Loading…